
In pharma's AI transformation, the technology was never the hard part — fixing the operating model that has to act on what AI surfaces is.

Erik Nordkamp is a health and life sciences expert at PA Consulting. Erik has over 25 years of experience in senior roles at major pharmaceutical companies, where he has led teams in strategy, business change, and operations, including CEO of General Medicines at Arcera, Chief Commercial Officer at Mundipharma, Managing Director at Pfizer UK and Senior Director Transformation & Lean Six Sigma at Eli Lilly. In addition to this, he led the led the ABPI as its President during the Brexit negotiations and was a Non-executive Director for Kings College London Trust. At PA, Erik works with pharmaceutical companies to shape growth plans, strengthen operations, and turn bold ideas into practical solutions that benefit patients.